Patil S D, Unadkat J D
Department of Pharmaceutics, School of Pharmacy, University of Washington, Seattle 98195, USA.
Am J Physiol. 1997 Jun;272(6 Pt 1):G1314-20. doi: 10.1152/ajpgi.1997.272.6.G1314.
The objective of the study was to determine the identity and kinetic characteristics of nucleoside transporters present in the brush-border membrane of the human jejunum. With use of brush-border membrane vesicles, uptake of [3H]uridine was stimulated two- to threefold by an inwardly directed Na+ gradient and was inhibited by both 100 microM thymidine and 100 microM guanosine nucleosides, which serve as model substrates for purine (N1, cif) and pyrimidine (N2, cit) transporters, respectively. [3H]thymidine and [3H]guanosine transport exhibited an overshoot phenomenon only in the presence of a Na+ gradient. Na(+)-thymidine uptake was inhibited by 100 microM cytidine or thymidine but not by guanosine, inosine, formycin B, or hypoxanthine. [3H]guanosine uptake was inhibited by 100 microM inosine, guanosine, or formycin B but not by thymidine or cytidine. Both adenosine and uridine inhibited uptake of [3H]thymidine and [3H]guanosine to a similar extent, indicating that both N1, cif and N2, cit Na(+)-nucleoside transporters are expressed in human jejunum. Enhanced uptake of Na(+)-thymidine by an inside-negative potential difference generated by K+ and valinomycin provides evidence that nucleoside transport is rheogenic, involving net transfer of a positive charge. The Hill coefficient was unity for all three substrates, indicating a Na(+)-nucleoside coupling stoichiometry of 1:1. At saturating Na+ concentration (150 mM) the kinetic parameters (n = 3-4) Michaelis-Menten constant and maximum velocity for uridine, thymidine, and guanosine uptake were 4.15 +/- 1.79, 2.74 +/- 0.58, 12.02 +/- 1.34 microM and 25.93 +/- 7.38, 16.10 +/- 3.64, 63.92 +/- 10.23 pmol.mg-1.10 s-1, respectively. These results suggest that, in contrast to the human kidney that expresses the N4 nucleoside transporter, the human jejunum expresses both N1 and N2 Na(+)-nucleoside transporters.
本研究的目的是确定人空肠刷状缘膜中存在的核苷转运体的特性及动力学特征。利用刷状缘膜囊泡,内向的Na⁺梯度可使[³H]尿苷的摄取增加2至3倍,且分别作为嘌呤(N1,cif)和嘧啶(N2,cit)转运体模型底物的100μM胸苷和100μM鸟苷核苷均可抑制其摄取。[³H]胸苷和[³H]鸟苷的转运仅在存在Na⁺梯度时表现出过冲现象。Na⁺-胸苷摄取可被100μM胞苷或胸苷抑制,但不受鸟苷、肌苷、间型霉素B或次黄嘌呤抑制。[³H]鸟苷摄取可被100μM肌苷、鸟苷或间型霉素B抑制,但不受胸苷或胞苷抑制。腺苷和尿苷对[³H]胸苷和[³H]鸟苷摄取的抑制程度相似,表明N1,cif和N2,cit Na⁺-核苷转运体均在人空肠中表达。由K⁺和缬氨霉素产生的内负电位差增强了Na⁺-胸苷的摄取,这提供了核苷转运是生电性的证据,涉及正电荷的净转移。所有三种底物的希尔系数均为1,表明Na⁺-核苷偶联化学计量比为1:1。在饱和Na⁺浓度(150 mM)下,尿苷、胸苷和鸟苷摄取的动力学参数(n = 3 - 4)米氏常数和最大速度分别为4.15±1.79、2.74±0.58、12.02±1.34μM和25.93±7.38、16.10±3.64、63.92±10.23 pmol·mg⁻¹·10 s⁻¹。这些结果表明,与表达N4核苷转运体的人肾不同,人空肠表达N1和N₂ Na⁺-核苷转运体。